Abstract
Deficiencies in the factors that determine health, as well as damaging factors to the body, can create weakened states in the body. These disordered states are not always, or immediately, pathologies that lead to a clinical presentation. They are the ground states of eventual pathology. In their earlier phases, they may lead to hypofunction of a system and some lower intensity symptoms. They are observable as a breakdown of the body via its extracellular matrix, its cellular proteasome, the microbiome, the immune system, and genetic repair mechanisms, as well as its bioregulatory control systems. In time, this will lead to disordered circulation and communication in that tissue or organ. This further leads to inflammation, immune involvement, and eventually fibrosis and drastic decline of function. These states are ones that naturopathic physicians and patients need to direct their efforts to ameliorating, reversing, and preventing, because they spawn processes of dysfunction and degeneration we know as disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wu H, Wang Y, Zhang Y, Xu F, Chen J, Duan L, et al. Breaking the vicious loop between inflammation, oxidative stress and coagulation, a novel anti-thrombus insight of nattokinase by inhibiting LPS-induced inflammation and oxidative stress. Redox Biol. 2020;32:101500.
Mihm S. Danger-associated molecular patterns (DAMPs): molecular triggers for sterile inflammation in the liver. Int J Mol Sci. 2018;19:E3104.
Yuan J, Amin P, Ofengeim D. Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases. Nat Rev Neurosci. 2019;20(1):19–33.
Doney E, Cadoret A, Dion-Albert L, Lebel M, Menard C. Inflammation-driven brain and gut barrier dysfunction in stress and mood disorders. Eur J Neurosci. 2022;55:2851–94.
Catorce MN, Gevorkian G. LPS-induced murine neuroinflammation model: main features and suitability for pre-clinical assessment of nutraceuticals. Curr Neuropharmacol. 2016;14(2):155–64.
Trovato Salinaro A, Pennisi M, Di Paola R, Scuto M, Crupi R, Cambria MT, et al. Neuroinflammation and neurohormesis in the pathogenesis of Alzheimer’s disease and Alzheimer-linked pathologies: modulation by nutritional mushrooms. Immun Ageing. 2018;14(15):8. https://pubmed.ncbi.nlm.nih.gov/29456585
Troubat R, Barone P, Leman S, Desmidt T, Cressant A, Atanasova B, et al. Neuroinflammation and depression: a review. Eur J Neurosci. 2021;53(1):151–71.
Zheng Z-H, Tu J-L, Li X-H, Hua Q, Liu W-Z, Liu Y, et al. Neuroinflammation induces anxiety- and depressive-like behavior by modulating neuronal plasticity in the basolateral amygdala. Brain Behav Immun. 2021;91:505–18.
Lloyd-Price J, Abu-Ali G, Huttenhower C. The healthy human microbiome. Genome Med. 2016;8(1):51.
Dominguez-Bello MG, Godoy-Vitorino F, Knight R, Blaser MJ. Role of the microbiome in human development. Gut. 2019;68(6):1108–14.
Weiss GA, Hennet T. Mechanisms and consequences of intestinal dysbiosis. Cell Mol Life Sci. 2017;74(16):2959–77.
Oka T, Hikoso S, Yamaguchi O, Taneike M, Takeda T, Tamai T, et al. Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature. 2012;485(7397):251–5.
Ruan L, Zhou C, Jin E, Kucharavy A, Zhang Y, Wen Z, et al. Cytosolic proteostasis through importing of misfolded proteins into mitochondria. Nature. 2017;543(7645):443–6.
Meyer JN, Leuthner TC, Luz AL. Mitochondrial fusion, fission, and mitochondrial toxicity. Toxicology. 2017;391:42–53.
Huang T, Song X, Yang Y, Wan X, Alvarez AA, Sastry N, et al. Autophagy and hallmarks of cancer. Crit Rev Oncog. 2018;23(5–6):247–67.
Cerri S, Blandini F. Role of autophagy in Parkinson’s disease. Curr Med Chem. 2019;26(20):3702–18.
Chang MT, Asthana S, Gao SP, Lee BH, Chapman JS, Kandoth C, et al. Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. Nat Biotechnol. 2016;34(2):155–63.
Pickup MW, Mouw JK, Weaver VM. The extracellular matrix modulates the hallmarks of cancer. EMBO Rep. 2014;15(12):1243–53.
Gonze D, Ruoff P. The Goodwin oscillator and its legacy. Acta Biotheor. 2021;69:857–74.
Franco E, Galloway KE. Feedback loops in biological networks. Methods Mol Biol. 2015;1244:193–214.
Spiga F, Walker JJ, Gupta R, Terry JR, Lightman SL. 60 Years of neuroendocrinology: glucocorticoid dynamics: insights from mathematical, experimental and clinical studies. J Endocrinol. 2015;226(2):T55–66.
Gjerstad JK, Lightman SL, Spiga F. Role of glucocorticoid negative feedback in the regulation of HPA axis pulsatility. Stress. 2018;21(5):403–16.
Goldstein DS. Concepts of scientific integrative medicine applied to the physiology and pathophysiology of catecholamine systems. Compr Physiol. 2013;3(4):1569–610.
Parmley WW. Pathophysiology of congestive heart failure. Clin Cardiol. 1992;15(Suppl 1):I5–12.
Kaur D, Tiwana H, Stino A, Sandroni P. Autonomic neuropathies. Muscle Nerve. 2021;63(1):10–21.
Dinan TG, Cryan JF. The microbiome-gut-brain axis in health and disease. Gastroenterol Clin North Am. 2017;46(1):77–89.
O’Mahony SM, Clarke G, Borre YE, Dinan TG, Cryan JF. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav Brain Res. 2015;277:32–48.
Brown AE, Walker M. Genetics of insulin resistance and the metabolic syndrome. Curr Cardiol Rep. 2016;18(8):75. https://pubmed.ncbi.nlm.nih.gov/27312935.
Montoro-Huguet MA, Belloc B, DomÃnguez-Cajal M. Small and large intestine (I): malabsorption of nutrients. Nutrients. 2021;13(4):1254.
Dev R. Measuring cachexia-diagnostic criteria. Ann Palliat Med. 2019;8(1):24–32.
Evans WJ, Morley JE, Argilés J, Bales C, Baracos V, Guttridge D, et al. Cachexia: a new definition. Clin Nutr. 2008;27(6):793–9.
Liska DJ. The detoxification enzyme systems. Altern Med Rev. 1998;3(3):187–98.
Dufault R, Berg Z, Crider R, Schnoll R, Wetsit L, Bulls WT, et al. Blood inorganic mercury is directly associated with glucose levels in the human population and may be linked to processed food intake. Integr Mol Med. 2015;2(3).
Rea WJ. History of chemical sensitivity and diagnosis. Rev Environ Health. 2016;31(3):353–61.
Karamanos NK, Theocharis AD, Piperigkou Z, Manou D, Passi A, Skandalis SS, et al. A guide to the composition and functions of the extracellular matrix. FEBS J. 2021;288:6850–912.
Theocharis AD, Manou D, Karamanos NK. The extracellular matrix as a multitasking player in disease. FEBS J. 2019;286(15):2830–69.
Hynes RO. The extracellular matrix: not just pretty fibrils. Science. 2009;326(5957):1216–9.
Pischinger A. In: Heine H, editor. The extracellular matrix and ground regulation. Berkely: North Atlantic Books; 2007.
Wight TN, Kang I, Evanko SP, Harten IA, Chang MY, Pearce OMT, et al. Versican—a critical extracellular matrix regulator of immunity and inflammation. Front Immunol. 2020;11:512.
Bonnans C, Chou J, Werb Z. Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol. 2014;15(12):786–801.
Bernard C. An introduction to the study of experimental medicine. Chelmsford: Courier Corporation; 1957.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Smith, F. (2022). States of Ill Health: The Ground of Clinical Presentations. In: Naturopathic Medicine. Springer, Cham. https://doi.org/10.1007/978-3-031-13388-6_7
Download citation
DOI: https://doi.org/10.1007/978-3-031-13388-6_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-13387-9
Online ISBN: 978-3-031-13388-6
eBook Packages: MedicineMedicine (R0)